Chlorhexidine Gluconate (CHG) Applicators, Procedural

The Defense Health Agency's Medical Logistics Directorate, in collaboration with the Defense Logistics Agency Troop Support Medical Prime Vendor Program, is seeking qualified suppliers to establish a Qualified Suppliers Listing for procedural Chlorhexidine Gluconate (CHG) Applicators. The initiative aims to identify vendors capable of providing sterile, non-latex applicators in various sizes, with an estimated annual demand of over 800,000 units across military treatment facilities and operational units within the Military Health System. Participation requires vendors to be registered in the DAPA Management System, have an agreement with current DoD prime vendors, and ensure products are manufactured in TAA-compliant countries, with detailed documentation on product origin, labeling, and regulatory compliance. The process involves submitting a comprehensive package by January 9, 2025, including product specifications, certifications, and supporting literature, with evaluations conducted by a panel of experts. Successful vendors will be invited to submit pricing proposals in February 2025, with the potential to be included in a standardization action, although this does not guarantee sales volume or constitute a contractual obligation. The overall effort emphasizes product quality, regulatory adherence, and regional distribution readiness to support military medical operations.